SGX Group has entered a licensing agreement with MSCI to launch up to 100 new equity derivatives contracts.
Loh Boon Chye
The move is set to bolster SGX’s current global derivatives franchise, and the firm has confirmed that it initially plans to unveil approximately 40 futures and options contracts spanning major developed and emerging markets economies.
Specifically, the product suite will cover MSCI’s global developed market benchmarks, key APAC single-country indexes and emerging markets Asia sector indexes.
Loh Boon Chye, chief executive of SGX Group, commented, “SGX has built a distinct capability in creating markets around the exposures that global investors need. This is about taking the benchmarks that matter to institutional portfolios and building the infrastructure that makes them tradable, liquid and risk managed.
“As portfolios are increasingly managed across regions, themes and benchmark suites, our comprehensive MSCI suite gives investors a broader platform to manage global equity risk through one trusted venue.”
Read more – CIBC joins SGX FX as liquidity provider
The new contracts are expected to enhance the tools currently available to investors looking to manage equity risk across their global portfolios.
Currently, SGX provides listed access to key Asian exposures, such as in China, Japan, Taiwan and ASEAN member countries.
The contracts agreement with MSCI is set to target key global, regional and sector-specific products used for capital allocation and risk management, and will bolster SGX’s positioning as an offshore venue for centrally cleared portfolio hedging and benchmark exposure within a single platform.
“This agreement reflects our commitment to ensuring that MSCI’s most critical benchmarks are accessible to investors wherever they manage risk, and we are pleased to expand our long-standing partnership with SGX to make a comprehensive suite of MSCI’s global and regional indexes available to institutional investors,” added Henry Fernandez, chair and chief executive of MSCI.
Enhancing its current derivatives offering has been a core focus for SGX in recent months, and in December 2025, the firm announced that Marex would serve as a clearing firm for SGX’s bitcoin and Ethereum perpetual futures products.
The move allowed Marex to support SGX in facilitating institutional traders’ access to continuous bitcoin or Ethereum exposure providing central clearing to minimise counterparty risk, and offer greater operational transparency.